Drug Discovery Centre
Drug Discovery Centre Navigation
Background
The Drug Discovery Centre:
We are a cross-faculty resource, hosted by Medicine and based in the Laboratory Block at Charing Cross Hospital. For more details, please see our About Us page.
Our mission:
To translate the wealth of Imperial’s healthcare-related research into drug discovery projects and ultimately new medicines.
News & Updates
DDC to provide project management support for new "Therapeutic Primer Fund" (February 2012)
Imperial NIHR Biomedical Research Centre (BRC) and Imperial Innovations are pleased to announce a call for proposals under the auspices of their newly created Therapeutic Primer Fund.
Imperial is keen to promote the discovery and development of therapeutics for areas of unmet medical need, and this fund has been established to pump-prime the early stages of drug/therapeutic discovery within the Imperial Academic Health Science Centre (Imperial College London and Imperial College Healthcare NHS Trust environments).
Any therapeutic project originated at Imperial (including small molecule, biological and cell therapy approaches) that aims to deliver a section of work at any stage from target validation through to first-time-in-man will be eligible for funding. Pure clinical projects are outside the scope of this call as they have alternate funding schemes available.
This closing date for expressions of interest is Friday 30th March.
Full details of the call together with the application form are in the document below.
DDC move sites: now based at Charing Cross Hospital (October 2011)
The Drug Discovery Centre has moved sites as of October 3rd. Both offices and laboratories are now based in the Laboratory Block of Charing Cross Hospital. Our new contact details are:
Address:
Imperial College London,
Charing Cross Hospital Campus, 5L17 Laboratory Block
St Dunstans Road,
London W6 8RP
Phone numbers:
| Personnel | New phone number |
| Katie Chapman | 020 331 10178 |
| Hayley Cordingley | 020 331 10178 |
| Albert Jaxa-Chamiec | 020 331 10177 |
| Caroline Low | 020 331 10176 |
| Kathy Scott | 020 331 10178 |
| Cathy Tralau-Stewart | 020 331 10179 |
For details of how to reach the site view this link: http://www3.imperial.ac.uk/campusinfo/charingcross
We look forward to receiving visitors in the new facilities.
DDC lead discussion in Thomson Reuters Webinar: Target Validation (August 2011)
Dr Cathy Tralau-Stewart, head of the Drug Discovery Centre at Imperial, was a key speaker at the well attended Webinar "Target Validation: the key to more efficient drug discovery" organised by Thomson Reuters on August 3rd.
The debate concerned how to improve early target validation and accelerate development of novel drug candidates. Specific topics included:
- How can we improve success rates?
- Are optimized animal models the only way to go or are there alternatives?
- What added benefits are realized from the inclusion of molecular information? Can we do target validation in patients?
- Are the lessons of yesterday an indication of success tomorrow?
Interest was lively, and the webinar is available to listen to via this link.
Contact Details
E-mail:
Phone:
Post:
+44 (0)20 331 10179
Head of Drug Discovery Centre,
Imperial College London,
Charing Cross Hospital Campus,
5L17 Laboratory Block,
St Dunstans Road,
London W6 8RP.
